Related Experiment Videos
[Vitamin prophylaxis for immature infant anemia (author's transl)]
Insights
Premature Infant Anemia (PIA) treatment with folic acid and vitamins improved blood parameters in newborns. Smaller infants showed better results, with observed differences in jaundice and transfusion needs between weight groups.
Area of Science:
- Neonatal Medicine
- Hematology
- Pediatric Nutrition
Context:
- Premature Infant Anemia (PIA) is multifactorial, stemming from insufficient erythropoiesis, reduced red blood cell lifespan, and increased hemolysis.
- Understanding these causes is crucial for developing effective prophylactic strategies in vulnerable newborns.
Purpose:
- To evaluate the efficacy of prophylactic treatment for Premature Infant Anemia (PIA) in newborns.
- To assess the impact of folic acid, alpha-tocopherol, and B vitamins (B1, B2, B6) plus vitamin C on key hematological and clinical parameters.
Summary:
- A study involving 208 premature infants (divided by birth weight) received prophylactic treatment.
- Evaluated parameters included weight gain, erythrocyte and reticulocyte counts, jaundice incidence, and transfusion requirements.
- Blood parameter improvements were noted, particularly in smaller infants, with distinct differences in jaundice and transfusion rates between the two groups.
Impact:
- The findings suggest a beneficial effect of the studied nutritional interventions on blood parameters in premature infants.
- Highlights the potential for tailored prophylactic strategies based on infant weight categories.
- Provides insights into managing anemia and related complications in premature neonates.
Abstract:
The cause of the Premature Infant Anemia (PIA) is mainly an insufficient erythropoiesis, a shorter mean-life of the red cells and in increased hemolysis. On these basis of prophylaxis has been attempted by treating newborns with folic acid, alpha-tocopherol and vitamins B1, B2, B6 and C. 208 premature babies have been treated (birth weight higher than 1750 nr. 171; birth weight less than 1750 nr. 37). Several parameters have been evaluated: weight gain, erythrocyte and reticulocyte count, jaundice occurrence and number of transfusions needed. The results on the blood parameters was good for the small babies group and sufficient for the others. Differences have been observed between the two groups for the occurrence of jaundice and transfusions.